Turku Bioscience Centre

Turku Bioscience Centre is an advanced core facility and research centre hosted jointly by University of Turku and Åbo Akademi University.

Our Expertise. Your Discoveries.

Research Services Contacts

NEWS

New diagnostic breakthrough predicts which head and neck cancer patients can be cured with surgery alone

July 23, 2025

Researchers from the University of Turku and Turku University Hospital, Finland, led by Docent Sami Ventelä and Professor Jukka Westermarck, have identified a novel diagnostic tool that can revolutionize the treatment guidance of head and neck squamous cell Read more

NEWS

Professor Riitta Lahesmaa has been elected as a member of EMBO

July 1, 2025

The European Molecular Biology Organization (EMBO) has selected Professor Riitta Lahesmaa from the University of Turku as its member. The organization annually elects new members based on scientific merit. EMBO is an international organization that Read more

All news

EVENT

The Sugarscience Th1nk Tank: Proteomics insights into type 1 diabetes development

August 12, 2025

More Info

August 12, 2025 @ 12:00 am - 1:00 pm - Karoliina Hirvonen recently completed her Ph.D. at the Turku Bioscience Centre, University of Turku and Event details

EVENT

34th BioCity Symposium: Transforming drug development for tomorrow

August 28, 2025

More Info

August 28, 2025 - August 29, 2025 @ 8:30 am - 5:00 pm - The 34th BioCity Symposium focuses on drug development across a range of Event details

All events

10

Core Facilities

Providing cutting-edge biomedical research services through advanced technologies and expert support.

16 + 12

Research & Affiliate Groups

Collaborating across disciplines to drive innovative solutions and breakthrough discoveries.

40+

Doctoral Researchers Graduated

Empowering the next generation of leaders through rigorous academic training and mentorship.

PUBLICATION

Secreted Clever-1 modulates T cell responses and impacts cancer immunotherapy efficacy

Stuart Prince et al.

Theranostics. 2025 Jun 23;15(15):7501-7527. doi: 10.7150/thno.110544. eCollection 2025.

Published on August 4, 2025

Rationale: Clever-1 is a multifunctional scavenger receptor that promotes immunosuppressive activity in macrophages, contributing to tumor immune evasion. Its high expression correlates with resistance to Read more

PUBLICATION

Phosphoproteomic analysis reveals the diversity of signaling behind ErbB-inhibitor-induced phenotypes

Katri Vaparanta et al.

FEBS J. 2025 Jul 24. doi: 10.1111/febs.70197. Online ahead of print.

Published on July 24, 2025

The impact of kinase inhibitors on the phosphoproteome has been rarely investigated at a whole-organism level. Here, we performed a phosphoproteomic analysis in embryonic zebrafish Read more

PUBLICATION

Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial

Edward Chesney et al.

Neuropsychopharmacology. 2025 Jul 24. doi: 10.1038/s41386-025-02175-3. Online ahead of print.

Published on July 23, 2025

In patients with schizophrenia, cannabis use exacerbates symptoms and can lead to a relapse of psychosis. Some experimental studies in healthy volunteers suggest that pre-treatment Read more

PUBLICATION

Correction: The PP2A regulator IER5L supports prostate cancer progression

Jana R Crespo et al.

Cell Death Dis. 2025 Jul 22;16(1):545. doi: 10.1038/s41419-025-07802-x.

Published on July 22, 2025

No abstract

PUBLICATION

LIMA1-alpha staining predicts curative intent surgery response in HPV negative head and neck cancer

Xi Qiao et al.

EMBO Mol Med. 2025 Jul 17. doi: 10.1038/s44321-025-00266-8. Online ahead of print.

Published on July 17, 2025

In many solid cancer types, surgery alone could be a sufficient first therapy option for a significant number of cancer patients. However, there are currently Read more

PUBLICATION

EPLINα controls integrin recycling from Rab21 endosomes to drive breast cancer cell migration

Niklas Z Jäntti et al.

Dev Cell. 2025 Jul 9:S1534-5807(25)00403-4. doi: 10.1016/j.devcel.2025.06.025. Online ahead of print.

Published on July 16, 2025

Epithelial protein lost in neoplasm (EPLIN), an actin-binding protein, has been described as both a tumor promoter and tumor suppressor in different cancers. The roles Read more

All publications

BLOG

From the Lab to the Stage: My 3MT Experience

May 20, 2025

I had the opportunity to present my PhD research in the finals of the University of Turku 3MT competition. It was a unique and rewarding experience to summarize my work in under three minutes to Read more

BLOG

Grateful to Be a Runner-Up in the University of Turku’s 3MT Competition!

March 10, 2025

I am excited and thankful to have been chosen as a Runner-Up in the Three Minute Thesis (3MT®) competition at the University of Turku on Wednesday, 5 March 2025. This experience has been thrilling, challenging, Read more

All blog posts

Turku Bioscience Centre Introduction Video

"We very much welcome you to contact or visit the Centre if you have a research problem or if you want to access specific technologies or infrastructure services."

600+

Published Research Articles

200+

Academic & Industrial Users

9.6M+

Average Annual Funding